Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 563

1.

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.

Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, Feely F, Pyo CW, Ferrari G; HVTN 505 Team, Frank I, Karuna ST, Swann EM, Mascola JR, Graham BS, Hammer SM, Sobieszczyk ME, Corey L, Janes HE, McElrath MJ, Gottardo R, Gilbert PB, Tomaras GD.

J Clin Invest. 2019 Oct 7. pii: 126391. doi: 10.1172/JCI126391. [Epub ahead of print]

2.

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.

Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, Pantaleo G, Ding S, McElrath MJ, De Rosa SC, Montefiori DC, Ferrari G, Tomaras GD, Keefer MC; HVTN 105 Protocol Team and the NIAID HIV Vaccine Trials Network.

J Clin Invest. 2019 Sep 30. pii: 128699. doi: 10.1172/JCI128699. [Epub ahead of print]

3.

Mapping the Lineage Relationship between CXCR5+ and CXCR5- CD4+ T Cells in HIV-Infected Human Lymph Nodes.

Del Alcazar D, Wang Y, He C, Wendel BS, Del Río-Estrada PM, Lin J, Ablanedo-Terrazas Y, Malone MJ, Hernandez SM, Frank I, Naji A, Reyes-Terán G, Jiang N, Su LF.

Cell Rep. 2019 Sep 17;28(12):3047-3060.e7. doi: 10.1016/j.celrep.2019.08.037.

4.

Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial.

Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X.

J Virol. 2019 Aug 21. pii: JVI.02041-18. doi: 10.1128/JVI.02041-18. [Epub ahead of print]

PMID:
31434737
5.

A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.

Frank I, Acharya A, Routhu NK, Aravantinou M, Harper JL, Maldonado S, Sole Cigoli M, Semova S, Mazel S, Paiardini M, Derby N, Byrareddy SN, Martinelli E.

Sci Rep. 2019 Aug 19;9(1):12078. doi: 10.1038/s41598-019-48354-3.

6.

Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy.

Yang DY, Frank I, Avant RA, Miller AR, Thapa P, Boorjian SA, Tollefson MK.

Urol Oncol. 2019 Aug 17. pii: S1078-1439(19)30246-7. doi: 10.1016/j.urolonc.2019.06.017. [Epub ahead of print]

PMID:
31427158
7.

Impacts of previous heatstroke history on physiological parameters eHSP72 and biomarkers of oxidative stress in military working dogs.

Bruchim Y, Aroch I, Nivy R, Baruch S, Abbas A, Frank I, Fishelson Y, Codner C, Horowitz M.

Cell Stress Chaperones. 2019 Sep;24(5):937-946. doi: 10.1007/s12192-019-01020-z. Epub 2019 Aug 11.

PMID:
31402428
8.

Fluorine-18-fluoro-2-deoxy-d-glucose PET-CT aids in detection of soft-tissue injuries for dogs with thoracic or pelvic limb lameness.

Frank I, Mann K, Duerr F.

Vet Radiol Ultrasound. 2019 Sep;60(5):575-585. doi: 10.1111/vru.12790. Epub 2019 Jul 29.

PMID:
31357247
9.

Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ.

Eur Urol Oncol. 2019 Jul;2(4):390-396. doi: 10.1016/j.euo.2018.09.004. Epub 2018 Sep 28.

PMID:
31277775
10.

Diagnostic Ultrasound Detection of Changes in Femoral Muscle Mass Recovery after Tibial Plateau Levelling Osteotomy in Dogs.

Frank I, Duerr F, Zanghi B, Middleton R, Lang L.

Vet Comp Orthop Traumatol. 2019 Sep;32(5):394-400. doi: 10.1055/s-0039-1688985. Epub 2019 May 29.

PMID:
31141823
11.

Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques.

Calenda G, Frank I, Arrode-Brusés G, Pegu A, Wang K, Arthos J, Cicala C, Rogers KA, Shirreff L, Grasperge B, Blanchard JL, Maldonado S, Roberts K, Gettie A, Villinger F, Fauci AS, Mascola JR, Martinelli E.

PLoS Pathog. 2019 May 13;15(5):e1007776. doi: 10.1371/journal.ppat.1007776. eCollection 2019 May.

12.

Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.

Ashare RL, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Collman RG, Wileyto EP, Schnoll R.

Drug Alcohol Depend. 2019 Jul 1;200:26-33. doi: 10.1016/j.drugalcdep.2019.03.011. Epub 2019 May 7.

PMID:
31082665
13.

Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Lyon TD, Frank I, Takahashi N, Boorjian SA, Moynagh MR, Shah PH, Tarrell RF, Cheville JC, Viers BR, Tollefson MK.

Clin Genitourin Cancer. 2019 Jun;17(3):216-222.e5. doi: 10.1016/j.clgc.2019.03.007. Epub 2019 Mar 25.

PMID:
31060857
14.

Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies.

Agarwal DK, Sharma V, Toussi A, Viers BR, Tollefson MK, Gettman MT, Frank I.

Eur Urol. 2019 Apr 19. pii: S0302-2838(19)30280-5. doi: 10.1016/j.eururo.2019.04.001. [Epub ahead of print]

PMID:
31010600
15.

A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.

Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, Herrera-Hernandez L, Cheville JC.

Hum Pathol. 2019 Jun;88:48-59. doi: 10.1016/j.humpath.2019.03.007. Epub 2019 Apr 1.

PMID:
30946934
16.

Technical Considerations of Single Port Ureteroneocystostomy Utilizing da Vinci SP Platform.

Hebert KJ, Joseph J, Gettman M, Tollefson M, Frank I, Viers BR.

Urology. 2019 Jul;129:236. doi: 10.1016/j.urology.2019.03.020. Epub 2019 Mar 30.

PMID:
30940479
17.

Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ.

World J Urol. 2019 Feb 25. doi: 10.1007/s00345-019-02689-8. [Epub ahead of print]

PMID:
30805684
18.

Comprehensive characterization of perioperative reoperation following radical cystectomy.

Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK.

Urol Oncol. 2019 Apr;37(4):292.e11-292.e17. doi: 10.1016/j.urolonc.2018.11.023. Epub 2019 Jan 22.

PMID:
30679081
19.

Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy.

Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ.

Int Braz J Urol. 2019 May-Jun;45(3):468-477. doi: 10.1590/S1677-5538.IBJU.2018.0196.

20.

Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ.

BJU Int. 2019 Jun;123(6):1011-1019. doi: 10.1111/bju.14612. Epub 2019 Jan 8.

PMID:
30623554
21.

Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer.

Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ.

Scand J Urol. 2018 Oct - Dec;52(5-6):340-348. doi: 10.1080/21681805.2018.1534886. Epub 2019 Jan 2.

PMID:
30600747
22.

Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.

Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S.

Urol Oncol. 2019 Jan;37(1):48-56. doi: 10.1016/j.urolonc.2018.10.013. Epub 2018 Nov 13.

PMID:
30446450
23.

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.

Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, Stancil BS, Ford SL, Patel P, Rinehart AR, Spreen WR, Margolis DA.

HIV Clin Trials. 2018 Aug;19(4):129-138. doi: 10.1080/15284336.2018.1511346. Epub 2018 Nov 16.

PMID:
30445896
24.

Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research.

Schnoll RA, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Mounzer K, Tyndale RF, Weisbrot J, Meline M, Collman RG, Ashare RL.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e36-e40. doi: 10.1097/QAI.0000000000001895.

PMID:
30399039
25.

A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease.

Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA.

World J Urol. 2019 Aug;37(8):1605-1613. doi: 10.1007/s00345-018-2551-9. Epub 2018 Nov 3.

PMID:
30392012
26.

Physical activity monitors can be successfully implemented to assess perioperative activity in urologic surgery.

Agarwal DK, Viers BR, Rivera ME, Nienow DA, Frank I, Tollefson MK, Gettman MT.

Mhealth. 2018 Sep 26;4:43. doi: 10.21037/mhealth.2018.09.05. eCollection 2018.

27.

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.

Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, Xu R, Ota-Setlik A, McElrath MJ, Hay CM; NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team.

PLoS One. 2018 Sep 20;13(9):e0202753. doi: 10.1371/journal.pone.0202753. eCollection 2018.

28.

The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.

Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC.

Eur Urol. 2018 Oct;74(4):489-497. doi: 10.1016/j.eururo.2018.06.003. Epub 2018 Jul 13.

PMID:
30017400
29.

Temporal trends in venous thromboembolism after radical cystectomy.

Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA.

Urol Oncol. 2018 Aug;36(8):361.e15-361.e21. doi: 10.1016/j.urolonc.2018.05.015. Epub 2018 Jun 7.

PMID:
29885792
30.

Identification and characterization of HIV-specific resident memory CD8+ T cells in human lymphoid tissue.

Buggert M, Nguyen S, Salgado-Montes de Oca G, Bengsch B, Darko S, Ransier A, Roberts ER, Del Alcazar D, Brody IB, Vella LA, Beura L, Wijeyesinghe S, Herati RS, Del Rio Estrada PM, Ablanedo-Terrazas Y, Kuri-Cervantes L, Sada Japp A, Manne S, Vartanian S, Huffman A, Sandberg JK, Gostick E, Nadolski G, Silvestri G, Canaday DH, Price DA, Petrovas C, Su LF, Vahedi G, Dori Y, Frank I, Itkin MG, Wherry EJ, Deeks SG, Naji A, Reyes-Terán G, Masopust D, Douek DC, Betts MR.

Sci Immunol. 2018 Jun 1;3(24). pii: eaar4526. doi: 10.1126/sciimmunol.aar4526.

31.

The Association of Aspirin Use with Survival Following Radical Cystectomy.

Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA.

J Urol. 2018 Nov;200(5):1014-1021. doi: 10.1016/j.juro.2018.05.119. Epub 2018 May 30.

PMID:
29857079
32.

Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.

Jehle J, Schöne B, Bagheri S, Avraamidou E, Danisch M, Frank I, Pfeifer P, Bindila L, Lutz B, Lütjohann D, Zimmer A, Nickenig G.

PLoS One. 2018 May 29;13(5):e0197751. doi: 10.1371/journal.pone.0197751. eCollection 2018.

33.

Density Functional Theory for Microwave Spectroscopy of Noncovalent Complexes: A Benchmark Study.

Kraus P, Frank I.

J Phys Chem A. 2018 May 31;122(21):4894-4901. doi: 10.1021/acs.jpca.8b03345. Epub 2018 May 17.

PMID:
29750513
34.

Pediatric Robotic Prostatectomy and Pelvic Lymphadenectomy for Embryonal Rhabdomyosarcoma.

Agarwal DK, Miest TS, Granberg CF, Frank I, Gargollo PC.

Urology. 2018 Sep;119:143-145. doi: 10.1016/j.urology.2018.03.027. Epub 2018 Apr 24.

PMID:
29702157
35.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.

36.

Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?

Tsima B, Ratcliffe SJ, Schnoll R, Frank I, Kolson DL, Gross R.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218768018. doi: 10.1177/2325958218768018.

37.

Examining the association between adiposity and biochemical recurrence after radical prostatectomy.

Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK.

Can Urol Assoc J. 2018 Jul;12(7):E331-E337. doi: 10.5489/cuaj.4923. Epub 2018 Mar 19.

38.

Constrained Chemical Dynamics of CO Dissociation/Hydrogenation on Rh Surfaces.

Kraus P, Frank I.

Chemistry. 2018 May 17;24(28):7188-7199. doi: 10.1002/chem.201705867. Epub 2018 Apr 30.

PMID:
29464790
39.

Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.

Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE.

Endocr Pathol. 2018 Sep;29(3):236-241. doi: 10.1007/s12022-018-9516-9.

PMID:
29453600
40.

Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.

Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP.

Eur Urol. 2018 May;73(5):772-780. doi: 10.1016/j.eururo.2018.01.005. Epub 2018 Feb 3.

PMID:
29398265
41.

BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.

Kolomeyer AM, Murphy KM, Traband A, Frank I, Kim BJ.

Retina. 2018 Apr;38(4):650-659. doi: 10.1097/IAE.0000000000002049. Review.

PMID:
29370030
42.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.

Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, Carpp LN, Hammer SM, Sobieszczyk M, Karuna S, Swann E, DeJesus E, Mulligan M, Frank I, Buchbinder S, Novak RM, McElrath MJ, Kalams S, Keefer M, Frahm NA, Janes HE, Gilbert PB, Tomaras GD.

J Infect Dis. 2018 Mar 28;217(8):1280-1288. doi: 10.1093/infdis/jiy008.

43.

Benchmark-Quality Semiexperimental Structural Parameters of van der Waals Complexes.

Kraus P, Obenchain DA, Frank I.

J Phys Chem A. 2018 Feb 1;122(4):1077-1087. doi: 10.1021/acs.jpca.7b10797. Epub 2018 Jan 19.

PMID:
29301068
44.

The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy.

Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK.

Clin Genitourin Cancer. 2018 Jun;16(3):e629-e636. doi: 10.1016/j.clgc.2017.11.003. Epub 2017 Dec 6.

PMID:
29289518
45.

Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.

Aravantinou M, Mizenina O, Calenda G, Kenney J, Frank I, Lifson JD, Szpara M, Jing L, Koelle DM, Teleshova N, Grasperge B, Blanchard J, Gettie A, Martinelli E, Derby N.

Front Microbiol. 2017 Dec 5;8:2342. doi: 10.3389/fmicb.2017.02342. eCollection 2017.

46.

Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.

Zattoni F, Morlacco A, Nehra A, Frank I, Boorjian SA, Thapa P, Karnes RJ.

Int Braz J Urol. 2018 May-Jun;44(3):491-499. doi: 10.1590/S1677-5538.IBJU.2017.0376.

47.

Integrin α4β7 Blockade Preferentially Impacts CCR6+ Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques.

Calenda G, Keawvichit R, Arrode-Brusés G, Pattanapanyasat K, Frank I, Byrareddy SN, Arthos J, Cicala C, Grasperge B, Blanchard JL, Gettie A, Reimann KA, Ansari AA, Martinelli E.

J Immunol. 2018 Jan 15;200(2):810-820. doi: 10.4049/jimmunol.1701150. Epub 2017 Dec 1.

48.

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC; HVTN 104 Protocol Team; and the NIAID HIV Vaccine Trials Network.

PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov.

49.

The chemokine receptor CCR2 maintains plasmacytoid dendritic cell homeostasis.

Cédile O, Jørgensen LØ, Frank I, Wlodarczyk A, Owens T.

Immunol Lett. 2017 Dec;192:72-78. doi: 10.1016/j.imlet.2017.10.012. Epub 2017 Oct 26.

PMID:
29106985
50.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, Finak G, Allen M, Tieu HV, Frank I, Sobieszczyk ME, Hannaman D, Gottardo R, Gilbert PB, Tomaras GD, Corey L, Clarke DK, Egan MA, Eldridge JH, McElrath MJ, Frahm N; NIAID HIV Vaccine Trials Network.

Clin Vaccine Immunol. 2017 Nov 6;24(11). pii: e00263-17. doi: 10.1128/CVI.00263-17. Print 2017 Nov.

Supplemental Content

Support Center